23 Grants
2021
Potential Role of Extracellular Vesicles for the Development of HIV Comorbidities
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL154859-02), $619,748USD, 2020-08-01 -- 2024-07-31
2020
Potential Role of Extracellular Vesicles for the Development of HIV Comorbidities
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL154859-01), $647,413USD, 2020-08-01 -- 2024-07-31
2018
Development of a Fully Humanized Antibody for Treating Lung Emphysema
Clauss, Matthias⋅HAY, DOUGLAS W and Petrache, Irina
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R44HL127873-04), $958,776USD, 09/01/2015 -- 07/31/2019
 
HIV-Nef protein and endothelial dysfunction
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL129843-04), $441,141USD, 07/06/2015 -- 04/30/2019
 
Humanized EMAP II mAb as a Novel Therapy for Viral-Associated Lung Injury
Bogatcheva, Natalia and Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R41HL135945-01A1), $281,155USD, 02/15/2018 -- 01/31/2019
2017
Development of a Fully Humanized Antibody for Treating Lung Emphysema
Clauss, Matthias⋅HAY, DOUGLAS W and Petrache, Irina
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 2R44HL127873-03), $715,140USD, 09/01/2015 -- 07/31/2019
 
HIV-Nef protein and endothelial dysfunction
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL129843-03), $445,197USD, 07/06/2015 -- 04/30/2019
 
The Role of EMAP II in Viral-Associated Acute Respiratory Distress Syndrome
Clauss, Matthias
U.S. Department Of Defense (Dod) (ID: W81XWH1710177), $212,992USD, 6/1/2017 -- 11/30/2018
2016
HIV-Nef protein and endothelial dysfunction
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL129843-02), $438,021USD, 07/06/2015 -- 04/30/2019
2015
Development of a Fully Humanized Antibody for Treating Lung Emphysema
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 6R43HL127873-02), $52,013USD, 12/20/2016 -- 02/28/2018
 
Development of a Fully Humanized Antibody for Treating Lung Emphysema
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R43HL127873-01), $227,766USD, 09/01/2015 -- 02/29/2016
 
HIV-Nef protein and endothelial dysfunction
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL129843-01), $456,077USD, 07/06/2015 -- 04/30/2019
 
HIV-Nef protein is disseminated in blood cells and causes endothelial dysfunction
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R21HL120390-02), $192,075USD, 04/01/2014 -- 03/31/2016
2014
HIV-Nef protein is disseminated in blood cells and causes endothelial dysfunction
Clauss, Matthias
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R21HL120390-01A1), $234,000USD, 04/01/2014 -- 03/31/2016
2012
HIV, Inflammation, and Endothelial Dysfunction
Clauss, Matthias and Gupta, Samir K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL095149-05), $744,909USD, 09/25/2008 -- 06/30/2014
2011
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.
Clauss, Matthias ( and Petrache, Irina
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL090950-04), $375,446USD, 07/08/2008 -- 05/31/2013
 
HIV, Inflammation, and Endothelial Dysfunction
Clauss, Matthias and Gupta, Samir K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL095149-04), $771,965USD, 09/25/2008 -- 06/30/2013
2010
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.
Clauss, Matthias ( and Petrache, Irina
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL090950-03), $375,724USD, 07/08/2008 -- 05/31/2012
 
HIV, Inflammation, and Endothelial Dysfunction
Clauss, Matthias and Gupta, Samir K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL095149-03), $878,381USD, 09/25/2008 -- 06/30/2013
2009
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.
Clauss, Matthias ( and Petrache, Irina
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL090950-02), $380,751USD, 07/08/2008 -- 05/31/2012
 
HIV, Inflammation, and Endothelial Dysfunction
Clauss, Matthias and Gupta, Samir K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 5R01HL095149-02), $900,940USD, 09/25/2008 -- 06/30/2013
2008
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.
Clauss, Matthias and Petrache, Irina
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL090950-01A1), $368,800USD, 07/08/2008 -- 05/31/2012
 
HIV, Inflammation, and Endothelial Dysfunction
Clauss, Matthias and Gupta, Samir K
National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) (ID: 1R01HL095149-01), $809,906USD, 09/25/2008 -- 06/30/2013